Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerStandard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell TumorsStart or STop Anticoagulants Randomised Trial (SoSTART)Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney FailureLong Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy StudyCapecitabine or Observation After Surgery in Treating Patients With Biliary Tract CancerFirst-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung CancerCisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal CancerMyeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple MyelomaA Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical TreatmentLUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based ChemotherapyThe BEACON Study (Breast Cancer Outcomes With NKTR-102)Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept StudyA Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and RefracDonor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological CancersEMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)The XENERA™-1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Post-menopausal Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
P6153
Q58849164-584DDD50-7698-4471-A140-7CE6C52A4200Q61864694-221D9A7D-9CB5-432B-9DF9-DF1E70B0C273Q61909847-5ECF700B-7F7C-4CB6-9D01-AB8E4D3B4605Q61920712-CA16C8DE-3C97-4A02-B7CF-E450108A80CBQ61921291-5B075175-58CD-42FD-8A7B-69298F644E39Q61922347-5597FB4F-BC9F-4D9D-9BCC-888FF743E040Q61924401-663E7750-558F-403C-9FA4-1C7B7EB83F50Q61934654-32363464-E55E-4036-A22D-5F5C3A62D37BQ61936447-8BE898F0-D05A-4045-978F-BF446B708236Q61979397-451A5C2A-2C22-4DD8-9407-7C764AD44BAEQ62040007-A306D2D5-8782-4897-BA4D-D0AFE9F70EA0Q62041950-39BD6963-464D-4FC6-99E5-2BDA90168A68Q63319514-7EB6A8C7-886C-4F3C-AFE5-B5A7389B8310Q63320307-D06C8AF1-D650-4E88-A498-77632D839D11Q63337535-0589118E-A119-48CF-ACED-FA7D3FE63D68Q63339113-346CC8EE-4DC7-4B31-83D1-115FA24D5050Q63340296-F7B3E5EA-2414-4E49-9560-0638B48AA46DQ63394905-1965F0EB-F637-40B0-8B12-A31372B972FFQ63573752-8F89C671-E0CD-450F-B8C6-949F236C8E96
P6153
description
Krankenhaus
@de
griya sakit
@jv
hospital de Reinu Xuníu
@ast
hospital in England
@en
hôpital
@fr
rumah sakik
@min
rumah sakit di Britania Raya
@id
rumoh sakét
@ace
ziekenhuis in het Verenigd Koninkrijk
@nl
בית חולים בממלכה המאוחדת
@he
name
Nottingham City Hospital
@en
type
label
Nottingham City Hospital
@en
prefLabel
Nottingham City Hospital
@en
P1566
P214
P244
P6366
P1566
P213
0000 0000 9962 2336
P214
P2427
grid.412920.c
P244
n2004119793
P3500
P370
emergency:No
P373
Nottingham City Hospital
P571
1903-01-01T00:00:00Z
P625
Point (-1.157778 52.990833)
P6366
2802921333